3.1.iv: Biotechnology Regulations

Jointly develop a regulatory pathway to ensure regulations surrounding the biotechnology sector are based on sound science.

Other Information:

Partner in Biotechnology by jointly developing a regulatory pathway to ensure regulations surrounding the sector are based on sound science, are transparent and supportive of policies that encourage investment in and commercialization of biotechnology, and promote trade in biotech goods and services. Both countries (i.e. US FDA working with the Indian FDA) should harmonize legislation to provide opportunities and protection for US as well as Indian companies in biotech related IPR. Extend the scope of the US-India R&D partnership to Nano-technology as well. Action: USG and GoI. For Biotechnology - US FDA and Indian FDA.

Stakeholder(s):

• US FDA


• Indian FDA

Indicator(s):

Indicator:1

Content